• Episode 11: ASCO Annual Meeting 2024 Commentary: Prostate Cancer

  • Jun 6 2024
  • Durée: 30 min
  • Podcast

Episode 11: ASCO Annual Meeting 2024 Commentary: Prostate Cancer

  • Résumé

  • Dr. Lalani and Dr. Wallis cover the utility of metformin, quality of life analyses, and optimizing treatment approaches for resistant prostate cancer, including the place for radioligand therapies.The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take home messages for practicing clinicians in the field of genitourinary (GU) cancers.

    Learn more about The View on GU: https://theviewongu.com

    This podcast has been made possible through financial support by Astellas, AstraZeneca, Bayer, Bristol Myers Squibb, Eisai, Ipsen, Merck, Novartis, Pfizer and TerSera.

    Voir plus Voir moins
activate_Holiday_promo_in_buybox_DT_T2

Ce que les auditeurs disent de Episode 11: ASCO Annual Meeting 2024 Commentary: Prostate Cancer

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.